CARR vs TERN · P/E 43, rev $5.15B vs $6.12B cap
Carrier Global Corp (CARR) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CARR revenue for 2024-12-31 was $5.15B. Net income was $5.71B. Revenue was down 14.0% from 2024-09-30 to 2024-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CARR and TERN stock pages for the full models.
Not investment advice.